| 일 | 월 | 화 | 수 | 목 | 금 | 토 |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 |
- China
- M&A
- hong kong
- taiwan
- sk
- capital gate
- acquisition
- Investment
- PEF
- cgi korea
- Confidential Agreement
- Korea
- case study
- Korea M&A
- LOI
- Letter of intent
- OTCBB
- buyout
- private equity
- CA
- Malaysia
- Bank
- Acquistion
- Japan Tobacco
- securities
- China Construction Bank
- Merger
- nda
- Japan
- LOTTE
- Today
- Total
Korea M&A Corporation
GS’ acquisition of Hugel to change domestic BTX, bio markets
As the GS consortium is certain to acquire Korea's botulinum toxin (BTX) developer, Hugel, industry watchers are paying keen attention to how the acquisition would change the company and the domestic BTX and bio markets. The four-party private equity fund formed by the GS Group, also participated in by IMM Investment, China's CBC Group, and the United Arab Emirates (UAE) Mubadala Investment Comp..
GS E&C, Hyundai eyeing Doosan Infracore
GS Engineering & Construction (E&C) and Hyundai Heavy Industries are eyeing taking a major stake in Doosan Infraore which is being put up for sale as part of Doosan Group's business normalization. "GS E&C and Hyundai Heavy Industries are included on the shortlist to possibly purchase a major stake. Given their core strengths, it makes sense for either of the firms to participate in the upcoming ..